This information was published on 2024-12-18T00:10:55 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2504291 (IR 1826448) |
| (220) |
30 Oct 2024
|
| (300) |
GB, 17 Jul 2024, UK00004076637
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical and medicinal preparations and substances; vaccines. |
| (540) | UTEBZI |
| (550) | Word |
| (730) |
Glaxo Group Limited
|
Find out more about publications on the About page.